Comparative study of pitavastatin and atorvastatin on efficacy and safety in patients with ischemic stroke
Yuan Yuan,Yan Xu,Xuguang Gao
DOI: https://doi.org/10.3877/cma.j.issn.1673-9248.2014.01.001
2014-01-01
Abstract:Objective To evaluate the efficacy about lipid regulation of pitavastatin and atorvastatin in treatment of patients with ischemic stroke, contrast to improve in the effectiveness of carotid atherosclerosis in patients with ischemic stroke.Methods The selected 70 patients with acute cerebral infarction were randomly divided into 2 groups,pitavastatin 2mg/night in 40 cases, including 23 patients with before circulation infarction patients, 14 patients with posterior circulation infarction, 3 patients with watershed infarction; atorvastatin 10 mg/night in 30 cases, including 16 patients with before circulation infarction patients, 14 patients with posterior circulation infarction. The total of treatment period is 6 months. Respectively before and after treatment for 2 weeks, 1 month, 3 months and 6 month follow-up, we record curative effect observation record index (lipid levels, bilateral carotid intima-media thickness), safety observation index (blood, urine routine, liver and kidney function, fasting blood glucose, creatine kinase, electrocardiogram), neurologic outcome (NIHSS and mRS score).Using SPSS statistical software to test 19.0, P < 0.05 for the difference was statistically signiifcant.Results After 6 months, LDL cholesterol (LDL-C) in pitavastatin treatment group significantly decreased by 18.5%(t=4.01,P<0.01), and LDL-C in the atorvastatin group significantly decreased by 21.0%(t=4.56,P<0.01), the LDL-C reduction were not significant difference between two groups (t=1.92,P=0.059). Pitavastatin treatment group after 6 months of right common carotid arteryIMT has decreased(t=1.92,P=0.063), and the soft plaque quantity decreased (χ2=0.33,P=0.85), but there was no statistically significant difference. Two groups of patients before and after treatment of electrocardiogram, urine routine, creatine phosphokinase, transaminase and serum creatinine levels had no significant change (P>0.05). Conclusions Pitavastatin may be similar to atorvastatin in reduction of LDL-C and the long-term effect of treatment of carotid artery atherosclerosis, The adverse reactions of pitavastatin are mild. Pitavastatin can be used in the treatment of hypercholesterolemia and atherosclerosis in patients with ischemic stroke.